TUESDAY, Dec. 3, 2024 (HealthDay News) — An accumulation of fat lurking around the organs of obese people is strongly linked to a buildup of Alzheimer’s-linked proteins in the brain, new research finds. Buildup of this visceral fat in middle age may boost levels of the two damaging brain proteins,Continue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90% during a three-year period compared to placebo, trial resultsContinue Reading
TUESDAY, Nov. 26, 2024 (HealthDay News) — The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid. However, the move would have to be approved by the new Trump administration. Right now, a law passed byContinue Reading
TUESDAY, Nov. 26, 2024 (HealthDay News) — The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1sContinue Reading
SATURDAY, Nov. 23, 2024 (HealthDay News) — So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance. Luckily, one expert fromContinue Reading
-690x550.jpg)
FRIDAY, Nov. 22, 2024 (HealthDay News) — How long Americans can expect to live varies dramatically — and the gap continues to widen. A new report says health inequalities have, in essence, created 10 Americas. These mutually exclusive populations are divided along familiar fault lines, including race, ethnicity, income andContinue Reading
FRIDAY, Nov. 22, 2024 (HealthDay News) — America’s kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows. GLP-1s like Ozempic, Wegovy, Mounjaro and Zepbound all work by making food less desirable, and it’s showing up in more foodContinue Reading
THURSDAY, Nov. 21, 2024 (HealthDay News) — A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed forContinue Reading
FRIDAY, Nov. 15, 2024 (HealthDay News) — Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study warns. About 213 million Americans aged 25 and older will be carrying around excess weight within 25 years,Continue Reading
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — Bottoms up: The type of alcohol you prefer may say something about your lifestyle, new research reveals. Beer drinkers are more likely to have an unhealthy lifestyle than folks who prefer wine or liquor, scientists report. Beer drinkers have lower-quality diets, are lessContinue Reading